Tonix Pharmaceuticals Holding (NASDAQ: TNXP) is a clinical-stage biopharmaceutical company focused on discovering and developing small molecules and biologics to treat psychiatric, pain and addiction conditions. Tonix’s lead product candidate, TNX-102 SL (the FDA has conditionally accepted “Tonmya” as the proposed trade name for TNX-102 SL for the treatment of PTSD), is in phase 3 development as a bedtime treatment for PTSD and fibromyalgia, and has received FDA Breakthrough Therapy Designation for PTSD. TNX-102 SL is also in development for agitation in Alzheimer’s disease and alcohol use disorder (AUD). The company is also developing TNX-601 as a daytime treatment for PTSD and depression; TNX-1600 for daytime treatment of PTSD; TNX-1300, which is in phase 2 development for the treatment of cocaine intoxication and has FDA Breakthrough Therapy Designation. Tonix’s preclinical pipeline includes TNX-1500, developed to prevent and treat organ transplant rejection and autoimmune conditions; TNX-1700, being developed to treat gastric and pancreatic cancers; TNX-801 to potentially prevent smallpox; and TNX-701 to prevent radiation effects are being advanced as medical countermeasures to improve biodefense. For more information, visit the company’s website at www.tonixpharma.com
About NetworkNewsWire
NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 888-902-4192 (U.S. Mobile Phones Only)
For more information, please visit https://www.networknewswire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.networknewswire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
NetworkNewsWire is part of the InvestorBrandNetwork.
